Barclays PLC Legend Biotech Corp Call Options Transaction History
Barclays PLC
- $327 Billion
- Q2 2024
Call Options
2 transactions
Others Institutions Holding LEGN
# of Institutions
205Shares Held
74.5MCall Options Held
371KPut Options Held
387K-
Price T Rowe Associates Inc Baltimore, MD11.5MShares$460 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$301 Million5.01% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$266 Million7.6% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$229 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.77MShares$191 Million1.06% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.7B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...